scispace - formally typeset
R

Rajagopal Ramesh

Researcher at University of Oklahoma Health Sciences Center

Publications -  162
Citations -  13172

Rajagopal Ramesh is an academic researcher from University of Oklahoma Health Sciences Center. The author has contributed to research in topics: Cancer & Lung cancer. The author has an hindex of 50, co-authored 155 publications receiving 11789 citations. Previous affiliations of Rajagopal Ramesh include University of Texas System & All India Institute of Medical Sciences.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Mitogen-Activated Protein Kinases and Their Role in Radiation Response

TL;DR: The MAPK signaling pathways are discussed, which play a major role in regulating cell growth, survival, and differentiation, and their roles in cellular radiation responses.
Journal ArticleDOI

Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector.

TL;DR: An improved extruded DOTAP:cholesterol (DOTAP:Chol) cationic liposome that efficiently delivers therapeutic tumor suppressor genes p53 and FHIT, which are frequently altered in lung cancer, to localized human primary lung cancers and to experimental disseminated metastases is described.
Journal Article

Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor.

TL;DR: In vitro, sMDA-7/IL-24 inhibited both endothelial cell differentiation and migration of endothelial cells induced by vascular endothelial growth factor and basic fibroblast growth factor, and the inhibitory effect was 10-50 times more potent than endostatin,IFN-gamma, and IFN-inducible protein 10 in vitro.